BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 1911585)

  • 21. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of second trimester abortion with mifepristone and gemeprost.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1993 Aug; 100(8):758-61. PubMed ID: 8399016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised trial of hypan versus gemeprost in cervical preparation prior to second trimester termination of pregnancy.
    Zamblera D; Thilaganathan B; Parsons J
    Br J Obstet Gynaecol; 1994 Jun; 101(6):543-4. PubMed ID: 8018648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamicel: a new technique for cervical dilatation before first trimester abortion.
    Nicolaides KH; Welch CC; MacPherson MB; Johnson IR; Filshie GM
    Br J Obstet Gynaecol; 1983 May; 90(5):475-9. PubMed ID: 6849849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of the progesterone antagonist, RU 486 (mifepristone), in preoperative cervical dilatation during the luteal phase. A randomized double-blind study].
    Fernandez H; Durlot F; Dubois C; Ulmann A; Frydman R
    Contracept Fertil Sex (Paris); 1990 Jan; 18(1):41-3. PubMed ID: 12283016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of prostaglandin E2 pessaries and laminaria tents for ripening the cervix before termination of pregnancy.
    Killick SR; Vaughan Williams CA; Elstein M
    Br J Obstet Gynaecol; 1985 May; 92(5):518-21. PubMed ID: 3857938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of RU-38486 on cervical ripening. Clinical studies.
    Lefebvre Y; Proulx L; Elie R; Poulin O; Lanza E
    Am J Obstet Gynecol; 1990 Jan; 162(1):61-5. PubMed ID: 2301519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical priming before first trimester aspiration abortion: a single blind study comparing gemeprost 1 mg and prostaglandin E2 10 mg pessaries.
    Mackenzie IZ; Jackson C; Mckinlay E; Millar J
    J Obstet Gynaecol (Lahore); 1990 Oct; 10(6):513-7. PubMed ID: 12284145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study.
    Rådestad A; Christensen NJ; Strömberg L
    Contraception; 1988 Sep; 38(3):301-12. PubMed ID: 3168450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological modulation of cervical compliance in the first and second trimesters of pregnancy.
    Calder AA; Greer IA
    Semin Perinatol; 1991 Apr; 15(2):162-72. PubMed ID: 1876872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of antiprogestin (RU 486) for termination of second trimester pregnancy.
    Gottlieb C; Bygdeman M
    Acta Obstet Gynecol Scand; 1991; 70(3):199-203. PubMed ID: 1927296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
    Lelaidier C; Baton-Saint-Mleux C; Fernandez H; Bourget P; Frydman R
    Hum Reprod; 1993 Mar; 8(3):492-5. PubMed ID: 8473474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.
    Grimes DA; Mishell DR; David HP
    Contraception; 1992 Jul; 46(1):1-10. PubMed ID: 1424618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
    el-Refaey H; Templeton A
    Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Rodger MW; Baird DT
    Contraception; 1989 Oct; 40(4):439-47. PubMed ID: 2582769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abortion: epidemiology, safety, and technique.
    Blumenthal PD
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):506-12. PubMed ID: 1504270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of damage to the cervix by dilatation for first-trimester-induced abortion by suction aspiration.
    Molin A
    Gynecol Obstet Invest; 1993; 35(3):152-4. PubMed ID: 8505006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravaginal misoprostol as a cervical ripening agent.
    Fletcher HM; Mitchell S; Simeon D; Frederick J; Brown D
    Br J Obstet Gynaecol; 1993 Jul; 100(7):641-4. PubMed ID: 8369246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.